Document is current
Any future updates will be listed below
-
Authors
UI-Haq, Zia
Causin, Luiz
Kamalati, Tahereh
Kahol, Durgesh
Vaikunthanathan, Trishan
Wong, Charlotte
Arebi, Naila
-
Funding
Funding for this research was provided by:
Janssen-Cilag Limited
- License Information
-
More Information
Article History
Received: 28 September 2024
Accepted: 10 December 2024
First Online: 30 December 2024
Declarations
:
: Ethics approval for the use of the Discover Platform for research was secured from the NHS Health Research Authority in October 2018. The REC reference is 18/WM/0323 and the IRAS project ID is 253449. Ethics approval from an institutional review board was not sought as all data were anonymised.
: Not applicable.
: DK was employed by Janssen-Cilag Ltd (a subsidiary of Johnson & Johnson) at the time that the study was conducted and currently owns Johnson & Johnson stock/stock options. TV is currently employed by Janssen-Cilag Ltd (a subsidiary of Johnson & Johnson) and owns Johnson & Johnson stock/stock options. NA has received grants and consultancy fees from Janssen, Lilly, Ferring and Abbvie. ZU-H, TK and CW declared no conflicts of interest. LC was employed by Janssen-Cilag Ltd (a subsidiary of Johnson & Johnson) at the time that the study was conducted. TK and ZU-H were employed by Imperial College Health Partners at the time that the study was conducted.
